Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Julphar
Cerilliant
Cantor Fitzgerald
Farmers Insurance
McKinsey
Healthtrust
Cipla
McKesson
Medtronic

Generated: August 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Pravastatin pharmaceuatical compositions having good stability
Abstract:A pharmaceutical composition is provided which has excellent stability, when dispersed in water has a pH of at least about 9, and includes a medicament which is sensitive to a low pH environment such as pravastatin, one or more fillers such as lactose and/or microcrystalline cellulose, one or more binders, such as microcrystalline cellulose (dry binder) or polyvinylpyrrolidone (wet binder), one or more disintegrating agents such as croscarmellose sodium, one or more lubricants such as magnesium stearate and one or more basifying agents such as magnesium oxide.
Inventor(s): Joshi; Yatindra M. (Piscataway, NJ), Chiesa; Pierina (South Orange, NJ), Jain; Nemichand B. (Monmouth Junction, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:07/703,326
Patent Claims: 1. A stabilized pravastatin composition, which comprises pravastatin and one or more basifying agents, compatible with pravastatin, to impart a desired pH of at least 9 to an aqueous dispersion of said composition.

2. The pravastatin composition as defined in claim 1 wherein said pravastatin is present in an amount within the range of from about 1 to about 60% by weight of the composition.

3. The pravastatin composition as defined in claim 1 wherein the basifying agent is present in an amount within the range of from about 1 to about 75% by weight of the composition.

4. The pravastatin composition as defined in claim 1 wherein the basifying agent is an alkali metal hydroxide, an alkaline earth metal hydroxide or ammonium hydroxide.

5. The pravastatin composition as defined in claim 4 wherein the basifying agent is MgO, Mg(OH).sub.2, Ca(OH).sub.2, NaOH, KOH, LiOH, NH.sub.4 OH, Al(OH).sub.3 or magaldrate.

6. The pravastatin composition as defined in claim 1 in the form of a tablet.

7. A method of stabilizing pravastatin for storage, which comprises including with pravastatin one or more basifying agents, compatible with pravastatin, to impart a desired pH of at least 9 to an aqueous dispersion of the pravastatin.

8. The method as defined in claim 7 wherein the pravastatin is in the form of a pharmaceutical composition.

9. The method as claimed in claim 8 wherein said pravastatin is present in an amount within the range of from about 1 to about 60% by weight of the composition.

10. The method as defined in claim 8 the basifying agent is present in an amount within the range of from about 1 to about 75% by weight of the composition.

11. The method as defined in claim 8 wherein the basifying agent is an alkali metal hydroxide, an alkaline earth metal hydroxide or ammonium hydroxide.

12. The method as defined in claim 8 wherein the basifying agent is MgO, Mg(OH).sub.2, Ca(OH).sub.2, NaOH, KOH, LiOH, NH.sub.4 OH, Al(OH).sub.3 or magaldrate.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Deloitte
Federal Trade Commission
Farmers Insurance
Boehringer Ingelheim
Medtronic
Chubb
Daiichi Sankyo
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot